The Latin America, Middle East and Africa Deep Brain Stimulation Devices Market would witness market growth of 17.2% CAGR during the forecast period (2019-2025). The emerging applications of deep brain stimulation technologies for Alzheimer's disease and tinnitus treatment have provided opportunities for both new and existing players in the industry. A major increase in neurologists' use of deep brain stimulators in the treatment of various neurological disorders is complementing market growth in Middle Eastern and African countries.
Growing numbers of patients suffering from dystonia-related involuntary movements, Parkinson's disease, and multiple sclerosis, and growing acceptance of minimally invasive procedures are expected to push market growth exponentially. An increase in the demand for minimally invasive procedures is also a high-impact rendering catalyst for the deep brain stimulation (DBS) devices market due to improved patient outcomes.
Advantages like reduced pain, high cost-effectiveness, safety, efficacy and fast recovery also contribute to increased demand. Factors responsible for replacing open/invasive surgery with minimally invasive surgery are lower incision wounds, better patient satisfaction, shorter hospital stay, postoperative complications and mortality rate. Moreover, the wound healing is quicker, and in conventional treatments the recovery time is longer than that. These advantages are cumulatively responsible for driving market growth for the DBS products.
Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Deep Brain Stimulation Devices Market in LAMEA is expected to register a CAGR of 17.2% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Market Segmentation:
By Applications
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
